Myriad’s GeneSight test evaluates how variations in multiple genes may influence an individual’s outcomes with certain medications prescribed to treat depression, anxiety, and other psychiatric conditions.
Read More
The new single test for the BD Max System also shows ability to detect UK and South African variants, and it can return results in 2 to 3 hours.
Read More
The alliance aims to make Spinal Muscular Atrophy testing mandatory in European newborn screening programs by 2025.
Read More
Researchers have identified patterns of maternal autoantibodies that point toward MAR ASD with 100% accuracy.
Read More
MultiMMR, an alternative to complex, multistep testing workflows, was able to identify causes of MMR deficiency often missed by current clinical tests.
Read More